CopenFast Trial-Fetal Growth and Glycemic Control in Pregnant Women with Type 1 or Type 2 Diabetes Using Faster-Acting Insulin Aspart or Insulin Aspart-A Randomized Controlled Trial

被引：0
|
作者：
Noergaard, Sidse K.
Mathiesen, Elisabeth R.
Norgaard, Kirsten
Clausen, Tine D.
Soholm, Julie
Holmager, Pernille
Do, Nicoline C.
Damm, Peter
Ringholm, Lene
机构：
来源：
DIABETES | 2023年 / 72卷
关键词：
D O I：
10.2337/db23-176-OR
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
176-OR
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Copenfast trial: foetal growth and glycaemic control in pregnant women with type 1 or type 2 diabetes randomised to faster-acting insulin aspart or insulin aspart
    Norgaard, S.
    Soholm, J.
    Mathiesen, E.
    Norgaard, K.
    Clausen, T.
    Holmager, P.
    Do, N.
    Damm, P.
    Ringholm, L.
    [J]. DIABETOLOGIA, 2023, 66 (SUPPL 1) : S122 - S122
  • [2] Improved Postprandial Glycemic Control with Faster-Acting Insulin Aspart in Subjects with Type 1 Diabetes Using CSII
    Bode, Bruce
    Hyveled, Liselotte
    Tamer, Soren Can
    Ybanez, Patria
    Demissie, Marek
    [J]. DIABETES, 2015, 64 : A253 - A253
  • [3] Faster-acting insulin aspart versus insulin aspart in the treatment of type 1 or type 2 diabetes during pregnancy and post-delivery (CopenFast): an open-label, single-centre, randomised controlled trial
    Norgaard, Sidse K.
    Soholm, Julie C.
    Mathiesen, Elisabeth R.
    Norgaard, Kirsten
    Clausen, Tine D.
    Holmager, Pernille
    Do, Nicoline C.
    Damm, Peter
    Ringholm, Lene
    [J]. LANCET DIABETES & ENDOCRINOLOGY, 2023, 11 (11): : 811 - 821
  • [4] Improved Postprandial Glycemic Control with Faster-Acting Insulin Aspart in Patients with Type 1 Diabetes Using Continuous Subcutaneous Insulin Infusion
    Bode, Bruce W.
    Johnson, Joseph A.
    Hyveled, Liselotte
    Tamer, Soren C.
    Demissie, Marek
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2017, 19 (01) : 25 - +
  • [5] IMPROVED POSTPRANDIAL GLYCAEMIC CONTROL WITH FASTER-ACTING INSULIN ASPART VS INSULIN ASPART IN SUBJECTS WITH TYPE 1 DIABETES USING CSII IN PUMPS
    Bode, B. W.
    Hyveled, L.
    Tamer, S. C.
    Demissie, M.
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2016, 18 : A40 - A40
  • [6] Faster-acting insulin aspart improves postprandial glycaemia versus insulin aspart in patients with type 1 diabetes mellitus
    Heise, T.
    Haahr, H.
    Jensen, L.
    Erichsen, L.
    Hompesch, M.
    [J]. DIABETOLOGIA, 2014, 57 : S57 - S57
  • [7] FASTER-ACTING INSULIN ASPART IMPROVES POSTPRANDIAL GLYCAEMIA VERSUS INSULIN ASPART IN PATIENTS WITH TYPE 1 DIABETES MELLITUS
    Heise, T.
    Haahr, H.
    Jensen, L.
    Erichsen, L.
    Hompesch, M.
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2015, 17 : A5 - A6
  • [8] Insulin aspart in pregnancy: Protocol for a randomized controlled trial comparing the safety and efficacy of insulin aspart and human insulin in the treatment of pregnant women with type 1 diabetes
    Hod, M
    Amiel, S
    Damm, P
    Dunne, F
    Heller, S
    Lertoft, B
    Mathiesen, E
    Mccance, D
    Visser, G
    [J]. DIABETES, 2003, 52 : A567 - A567
  • [9] Adding Faster-Acting Insulin Aspart to Basal Insulin Significantly Improved Glycemic Control: The Onset® 3 Trial
    Rodbard, Helena
    Tamer, Soren Can
    Velazquez, Maricela Vidrio
    Tripathy, Devjit
    Piletic, Milivoj
    Demissie, Marek
    [J]. DIABETES, 2016, 65 : A63 - A64
  • [10] Adding faster-acting insulin aspart to basal insulin significantly improved glycaemic control in adults with Type 2 diabetes: the onset 3 trial
    Saravanan, P.
    Rodbard, H.
    Tripathy, D.
    Velazquez, M. V.
    Demissie, M.
    Tamer, S. Can
    Piletic, M.
    [J]. DIABETIC MEDICINE, 2017, 34 : 69 - 69
12345